NCT01101581 · Interventional trial
Study of Veltuzumab and 90Y-Epratuzumab in Relapsed/Refractory, Aggressive NHL
Overall registry status Withdrawn
Phase 1 · Phase 2
Conditions Aggressive NHL, Diffuse Large B-cell Lymphoma, NHL, Non Hodgkin's Lymphoma
Delaware Valley sites
- University of Pennsylvania Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory